Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1986-9-26
|
| pubmed:abstractText |
Spina bifida, Chiari type II malformation, cerebral aqueduct stenosis and hydrocephalus are the most frequent association anomalies in the congenital malformation of the central nervous system (Warkany et al., 1958). They are potentially treatable and of clinical importance. But the relationship between hydrocephalus and Chiari type II malformation is still a controversial subject. A single oral dose of 240 mg/kg of ethylenethiourea (ETU) was given to Sprague Dawley (SD) rats on the 11th day of gestation. Fetuses were removed in the 20th day of gestation by cesarean sections; high incidence of spinal dysraphism associated with hindbrain crowding was found in these fetuses. They are similar to Arnold-Chiari malformation in humans. We used these experimental models to analyze the relationship between hydrocephalus and Chiari type II malformation. From the present investigation, no hydrocephalus or cerebral aqueduct stenosis was found in the experimental rat fetuses with the Arnold-Chiari malformation. So we do not consider the hydrodynamic theory that Chiari type II malformation was induced by increasing intracranial pressure in hydrocephalus. Hydrocephalus in the Arnold-Chiari malformation may not be the primary disorder but seems to be caused by plugging the foramen magnum in Chiari type II malformation. So the cerebrospinal fluid in the spinal subarachnoid space can not move upward to the cranial subarachnoid space for absorption to venous return. Cerebral aqueduct stenosis may be secondarily compressed by hydrocephalus and not be the primary development anomaly or acquired occlusion due to gliosis. This is in accord with the theory proposed by Russell and Donald (1935).(ABSTRACT TRUNCATED AT 250 WORDS)
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0255-6596
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
118-26
|
| pubmed:dateRevised |
2008-2-26
|
| pubmed:meshHeading |
pubmed-meshheading:3749365-Abnormalities, Drug-Induced,
pubmed-meshheading:3749365-Animals,
pubmed-meshheading:3749365-Arnold-Chiari Malformation,
pubmed-meshheading:3749365-Brain,
pubmed-meshheading:3749365-Ethylnitrosourea,
pubmed-meshheading:3749365-Female,
pubmed-meshheading:3749365-Fetus,
pubmed-meshheading:3749365-Hydrocephalus,
pubmed-meshheading:3749365-Male,
pubmed-meshheading:3749365-Neural Tube Defects,
pubmed-meshheading:3749365-Pregnancy,
pubmed-meshheading:3749365-Rats,
pubmed-meshheading:3749365-Rats, Inbred Strains
|
| pubmed:year |
1986
|
| pubmed:articleTitle |
The relationship between hydrocephalus and Chiari type II malformation in the experimental rat fetuses with Arnold-Chiari malformation.
|
| pubmed:publicationType |
Journal Article
|